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ABSTRACT
Objectives: The present aims to assess the level of urinary incontinence in experimental and control group, to assess the effectiveness of vaginal cone 
therapy on urinary incontinence in experimental group and control group and to associate the post-test level of urinary incontinence with the selected 
demographic variables among women in the experimental group.
Methods: A quantitative quasi-experimental research design was conducted among 60 women with urinary incontinence. Convenience sampling 
technique was used. Semi-structured interview method was used to collect the demographical data and level of urinary incontinence among women 
was assessed by urinary incontinence diagnosis questionnaire.
Results: Among 60 samples in experimental group 26 women had a moderate level of urinary incontinence, and 4 women had slight urinary 
incontinence whereas in control group 24 women had moderate level of urinary incontinence and 6 women had slight urinary incontinence. The study 
results show significant improvement in level of urinary incontinence among experimental group than the control group after the intervention at the 
level of p<0.05. This reveals that vaginal cone therapy is highly significant in the experimental group because pelvic muscle strength had improved and 
allows the patient to increase the physiological consciousness and promotes the muscle tone after the use of a vaginal cone.
Conclusion: This study proves that vaginal cone therapy is the effective non-pharmacological method, cost-effective method and had no side effects 
which can be used to treat female urinary incontinence.
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INTRODUCTION
Urinary incontinence is an involuntary leakage of urine which affects 
women of all ages, with prevalence increasing as the women ages. 
Although nulliparous women can have urinary incontinence, the 
incidence is higher in women who have given birth and increases with 
parity and also incidence increases in women with overweight [1]. 
The prevalence is 30–40% among young adult to middle-aged women 
and increases to 30–50% in older women. Urinary incontinence has 
traditionally been viewed as a social or hygienic problem, but it also 
has a major effect on quality of life and contributes to serious health 
problems, especially in older women [2].
Women can experience a spectrum of leakage ranging from loss of 
only drops or tablespoons or more depending on the severity of the 
urinary incontinence. The degree of incontinence a woman has is very 
subjective and personal to her [3]. Major complications of urinary 
incontinence are psychosocial problems which include embarrassment, 
negative self-perception, social isolation sleep disturbances, decreased 
quality of life, and restricted educational or leisure opportunities. Too 
many of them “live with” the condition too embarrassed to seek help 
or thinking that it is a “normal” part of aging and having children [3].
The first technique was described in 1948 by Kegel, who prescribed 
rapid voluntary contractions of the pelvic floor muscles. The author 
observed that 70% of the patients improved or were cured. However, 
even when provided with information on the anatomy and function of 
these muscles, 30% of the patients were unable to perform adequate 
voluntary. Use of vaginal cones to strengthen pelvic floor muscles was 
initially proposed by Plevnik in 1985 [4]. Vaginal cones are widely used 
in the treatment of incontinence in women and represent a simple 
and practical way to identify and strengthen the pelvic floor muscles. 
When inserted into the vagina, it stimulates learning of contraction of 
the pelvic floor muscles by retaining cones with increasing weights. 
Thus, reflex contractions or voluntary muscles to prevent the sliding 
of the cone out, promote the recruitment of pubococcygeous muscles, 
maximize gain of muscle strength, and decrease the urine losses.
Vaginal cones are specially designed medical device which is inserted 
into the vagina and held in situ by contractions of the pelvic floor 
muscles. Vaginal cone is a non-invasive effective mode of treatment in 
patients with urinary incontinence.
Oblasser et al. stated that vaginal cone therapy with pelvic floor muscle 
training enhances the muscle performance and thereby prevent or treat 
urinary incontinence [5].
Women suffer from urinary incontinence nearly half of the life shells. 
Stress urinary incontinence occurs most often in young adult females, 
middle-aged women suffer from mixed incontinence, and older women 
suffer from urge incontinence. During the investigator’s clinical 
experiences had noticed many women who failed to report the problem 
of urinary incontinence due to feeling ashamed, sad, and loneliness 
leading to decreased self-esteem and increase in anxiety. Most of the 
women were not willing to seek medical attention for this condition. 
This leads to an increasing alarm to treat urinary incontinence among 
women. The researcher has taken a step ahead to create awareness 
regarding urinary incontinence and reduce the level of urinary 
continence using vaginal cones.
The purpose of the study is (1) to assess the level of urinary incontinence 
in the experimental and control group, (2) to assess the effectiveness 
of vaginal cone therapy on urinary incontinence in the experimental 
group and control group, and (3) to associate the post-test level of 
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urinary incontinence with the selected demographic variables among 
women in the experimental group.
METHODS
A quantitative approach with quasi-experimental research design [6,7] 
was used to conduct the study in Obstetrics and Gynaecology Department 
both in the Outpatient and Inpatient Departments of Saveetha Medical 
College Hospital, Thandalam, Chennai, which is a super specialty 
hospital. The data were collected using a convenience sampling 
technique from 60 women with urinary incontinence. The inclusion 
criteria for the samples are women both multiparous and nulliparous 
women with urinary incontinence, who had undergone normal vaginal 
delivery and cesarean section with age between 30 and 70 years, who 
had delivered 2 months before, postmenopausal pelvic organ prolapse 
Stage I and II, slight and moderate urinary incontinence, who were 
available at the time of data collection, willing to participate in the 
present study and who understand Tamil/English. The exclusion criteria 
for the samples were women who had under treatment for urinary 
incontinence, with a history of urinary tract infection, with a history 
of neurological disease, pregnant women, with intrauterine devices, 
with reproductive tract infection, and with psychiatric illness. The data 
were collected from 8th December 2017 to 31st December 2017 after 
obtaining ethical clearance from the Institutional Ethical Committee of 
Saveetha Institute of Medical Science and Technology. The purpose of 
the study was explained to the samples and written informed consent 
was obtained from them. The demographic data were collected using a 
structured interview questionnaire, and the level of stress incontinence 
was assessed using the questionnaire for urinary incontinence 
diagnosis (QUID) which was developed by Catherine [8]. Before the 
treatment, the patient was taught pelvic floor muscles tightening. First 
cone No.1 was covered with male condom and inserted gently into the 
vagina in dorsal recumbent position with the cone tip and the nylon 
cord pointing downward. If the first cone sensation was not felt by 
the women cone number 2 was then inserted, the replacements were 
continued with consecutively heavier weights until a sensation of loss 
was perceived. The woman was then instructed to walk and not to 
contract her pelvic floor muscular for 1 min and to report any sensation 
of losing the device. The subject was instructed to walk for 15 min 
daily with the cone in her vagina without voluntary contracting her 
pelvic floor muscles. This procedure was continued for 2 weeks. Post-
test was conducted after 2 weeks to assess urinary incontinence using 
QUID [8].The data were analyzed using descriptive and inferential 
statistics. The sample characteristics were described using frequency 
and percentage. Pearson’s correlation coefficient [9,10] was used to 
assess the effectiveness of vaginal cone therapy among women with 
urinary incontinence in the experimental group. Chi-square [9,10] 
was used to associates post-test level of urinary incontinence with the 
selected demographic variables.
RESULTS
Section A: Sample characteristics
Among 60 samples, 30 belong to experimental group, majority 
12 (40%) were in the age group of 50–59 years, 19 (63.33%) had no 
formal education, 21 (70%) belonged to joint family, 17 (56.67%) were 
doing primary sector type of occupation, 11 (36.67%) women were 
multiparous, 29 (96.67%) had normal vaginal delivery, 18 (60%) had 
undergone institutional delivery, 25 (83.33%) had undergone delivery 
10 years back, 8 (26.67%) attained menopause at the age of 41–45 years, 
15 (50%) were in the stage of postmenopause, 9 (30%) had no pelvic 
organ prolapse, 3 (10%) had urinary incontinence before hysterectomy, 
16 (53.33%) had a body mass index (BMI) of 25–29.9 (overweight), and 
15 (50%) experiencing urinary incontinence for <1 year. Remaining 
30 samples belong to control group, majority 15 (50%) were in the age 
group of 50–59 years, 22 (73.33%) had no formal education, 15 (50%) 
belonged to joint and nuclear family, respectively, 17 (56.67%) were 
homemakers, 19 (63.33%) were multiparous, 27 (90%) had normal 
vaginal delivery, 18 (60%) had undergone institutional delivery, 
24 (80%) had undergone delivery 10 years back, 12 (40%) attained 
menopause at the age of 35–40 years, 21 (70%) were in the stage of 
postmenopause, 2 (6.67%) had 0 degree of pelvic organ prolapse, 
2 (6.7%) had urinary incontinence post hysterectomy, 18 (60%) had 
a BMI of 25–29.9 (overweight), and 17 (56.67%) experiencing urinary 
incontinence for 1–5 years.
Section B: Level of urinary incontinence among women
The prevalence of urinary incontinence in experimental group 26 
women had moderate level of urinary incontinence and 4 women had 
slight urinary incontinence whereas in control group 24 women had 
moderate level of urinary incontinence and 6 women had slight urinary 
incontinence [Table 1].
Section C: Effectiveness of vaginal cone therapy on urinary 
incontinence among women in the experimental and control group
Vaginal cone therapy which is administered to the women with urinary 
incontinence in the experimental group had a significant reduction in 
the level of urinary incontinence than the women in the control group 
at the level of p<0.05 level [Table 2].
Section D: Association of post-test level of urinary incontinence 
with selected demographic variables among women in the 
experimental group
Parity had shown statistically significant association with post-test 
level of urinary incontinence among women in the experimental 
group at p<0.05 level and the other variables had not shown statistical 
significance [Table 3].
DISCUSSION
The present study findings depict that in experimental group 26 
women had a moderate level of urinary incontinence and 4 women 
had slight urinary incontinence whereas in control group 24 women 
had moderate level of urinary incontinence and 6 women had slight 
urinary incontinence [Fig. 1]. The present study finding is supported 
by Kilic who conducted a study to determine the incidence and risk 
factors of urinary incontinence in women visiting family health centers 
in Turkey. The study results determined that most of the women had 
urinary incontinence, but only a few consulted the physician due to 
negative self-perception [11]. Hence, it was concluded from the above 
studies that the prevalence of moderate urinary incontinence is more 
when compared to that of slight urinary incontinence. Hence, there is a 
need for non-invasive treatment like vaginal cone therapy which can be 
encouraged and practiced to treat urinary incontinence at the minimal 
level.
Table 1: Frequency and percentage distribution of level of 
urinary incontinence among women in the experimental group 
and control group







n (%) n (%)
Slight urinary incontinence 4 (13.33) 6 (20.0)
Moderate urinary incontinence 26 (86.67) 24 (80.0)
N=60 (30+30)
Table 2: Effectiveness of vaginal cone therapy on urinary 
incontinence among women in the experimental and control 
group
Level of urinary incontinence Mean±SD Unpaired ‘t’ Value
Experimental group 3.23±1.41 t=2.353 
p=0.022, S*Control group 4.10±1.45
*p<0.05, S: Significant. n=60 (30+30). SD: Standard deviation
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In the present study, vaginal cone therapy which is administered to 
the women with urinary incontinence in the experimental group had 
a significant reduction in the level of urinary incontinence than the 
women in the control group. The level of urinary incontinence shows 
reduction than the control group at the level of p<0.05 level [Fig. 2]. 
This reveals that vaginal cone therapy was highly significant in the 
experimental group because pelvic muscle strength had improved 
and allows the patient to increase the physiological consciousness 
and promotes the muscle tone after the use of a vaginal cone. These 
findings were also supported by Ong et al., who determined the use 
of vibrance kegel device with pelvic floor muscle exercise for stress 
urinary incontinence through randomized controlled trial in Malaysia, 
43 samples. The results showed that using the vibrance kegel device 
resulted in significant early improvement in stress urinary incontinence 
scores, and pelvic muscle strength had improved significantly by the 
end of the study [12]. Thus, they concluded that the vaginal cone 
therapy strengthens the pelvic floor muscles and improves the bladder 
control thereby urinary incontinence is reduced/treated. Hence, the 
research hypothesis was accepted.
In the present study, there was a statistical significant association in 
parity with the post-test level of urinary incontinence among women 
in the experimental group at p<0.05 level and the other variables had 
not shown statistical significance. Pregnancy and childbirth stretches, 
weakens and injures the pelvic floor muscles which increase the risk 
of urinary incontinence in women with high parity. Vaginal cone 
therapy promotes the sensorimotor biofeedback which increases the 
muscle contraction and improves the urethral closure and maintains 
the continence. Thus, the present study was an attempt to address 
important issues related to urinary incontinence among women. Hence, 
it is evident that vaginal cone therapy reduces the level of urinary 
incontinence among women. More extensive studies are required to be 
encouraged to be done in this aspect.
The present study was also supported by Sumathi who determined 
the effectiveness of pelvic floor rehabilitation with a vaginal cone 
on continence and quality of life among women with stress urinary 
incontinence. The research design adopted for the study was 
randomized control trial done with 250 samples. The setting for the 
study was Obstetrics and Gynaecology Outpatient Department of Sri 
Ramachandra Hospital. The pre-test results of the study show pre-
test 2 (1.6%) of the women in the study group and 5 (4%) of the 
women in the control group had a mild level of UTS, 123 (98.4%) 
of the women in the study group, and 120 (96%) of women in the 
control group had a moderate level of UTS. The post-test results of 
the study show association with all the obstetrical variables such as 
parity, number of abortions, birth weight of the baby, and place of 
delivery at level of p<0.001 [13]. Akram et al. conducted a study on 
extractive spectrophotometric determination of some antimuscarinic 
antagonist in tablet formulations using Eriochrome Cyanine R the 
study results suggested that oxybutynin, solifenacin, tolterodine, and 
fesoterodine used for quality control and routine analysis where time, 
cost-effectiveness and high specificity of the analytical technique are 
of great importance. The works by relaxing the involuntary detrusor 
muscle in the wall of the bladder by blocking muscarinic/cholinergic 
receptors present on the surface of the muscle cells and thus prevents 
acetylcholine from acting on these receptors [14]. The study is also 
supported by Pankaj and Bala had conducted a study to assess the 
pathophysiology, mechanism and its management of overactive 
bladder syndrome. The results of the review provide information 
of OAB and its different therapies such as behavioral modification, 
drug therapy, and the combination of both. If the symptoms are 
not managed by these treatments, then invasive therapies such 
as botulinum toxin A injection, neuromodulator implants, and 
augmentation cystoplasty may be exploited for complete control and 
balancing the efficacy and complications or side effects of invasive 
therapies [15].
CONCLUSION
Vaginal cone therapy is an effective non-pharmacological method and 
cost-effective method to treat female urinary incontinence. The selected 
women became familiar and comfortable to practice vaginal cone. From 
the results of the study, it was concluded that vaginal cone therapy had 
no side effects and it is an easy and comfortable method which can be 
practiced for a long time to treat urinary incontinence.
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Fig. 1: Percentage distribution of the level of urinary incontinence 
among women in the experimental group and control group
Fig. 2: Effectiveness of vaginal cone therapy on urinary 
incontinence among women in the experimental and control 
group
Table 3: Association of post-test level of urinary incontinence with selected demographic variables among women in the experimental 
group
Demographic Variables Slight urinary incontinence Moderate urinary incontinence Chi-Square Value





1 0 (0) 5 (16.7)
2 7 (23.3) 4 (13.3)
3 5 (16.7) 6 (20.0)
4 0 (0) 3 (10.0)
*p<0.05, S: Significant n=30
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